Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting

Cesare Gridelli, Rolf Stahel, Benjamin Besse, Fortunato Ciardiello, Enriqueta Felip, Stefano Gasparini, Paolo Graziano, Antonio Rossi, Filippo de Marinis

Research output: Contribution to journalArticlepeer-review


Introduction: The Italian Association of Thoracic Oncology (AIOT) and the European Thoracic Oncology Platform (ETOP) realized the first conjunct educational meeting, open to European oncologists involved in the treatment of thoracic malignancies, entitled Advanced non-small cell lung cancer: new perspectives in first-line setting Methods: The educational meeting included 8 interactive talks, held by European key opinion leaders, and 5 related clinical cases in which the attendees, divided in working tables based on their country origin, were involved for interactive discussion. The aim of this course was to elucidate the differences or similarities among the European countries in the first-line treatment of patients affected by advanced non-small cell lung cancer (NSCLC). Results: Twenty-two attendees of the following countries participated: Austria, France, Italy, Spain, Swiss, and UK. As expected, some discrepancies between the groups were identified concerning the approach to the diagnostic phase, the choice of first-line regimen, the duration of treatment and the use of maintenance therapy. These discrepancies were mainly due to familiarity with specific therapies and lack of access to certain therapies due to local regulatory issues. Conclusion: The European Medicine Agency grants marketing of drugs in all Europe, regulatory agency of each country can register the drug, but can also deny public reimbursement thus restricting the options of the oncologist. The European Oncology Associations should join to their effort to achieve a uniform access to the cancer therapy for all patients in Europe.

Original languageEnglish
Pages (from-to)544-548
Number of pages5
JournalLung Cancer
Issue number3
Publication statusPublished - Dec 2011


  • AIOT
  • EGFR
  • ETOP
  • First-line
  • Histology
  • Maintenance

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research


Dive into the research topics of 'Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting'. Together they form a unique fingerprint.

Cite this